Status:
TERMINATED
COVID-19 Testing in Underserved and Vulnerable Populations
Lead Sponsor:
Jesse Nodora
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Heart Failure
Coronary Artery Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
As part of National Institutes of Health Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) program, the goal of the RADxUP study is to develop, test, and evaluate a rapid, scalable c...
Detailed Description
Pronounced inequities and disparities in coronavirus disease (COVID-19)COVID-19 morbidity and mortality have been reported, largely due to comorbid conditions and social determinants of health. Approx...
Eligibility Criteria
Inclusion
- Eligible participants will include asymptomatic men and women receiving care at participating community health centers with at least one clinic visit in the last year, age 21 years and over, with co-morbid conditions deemed by the Centers for Disease Control and Prevention to increase risk for severe COVID-19 illness, including heart failure, coronary artery disease, cancer, chronic kidney diseases, COPD, obesity, sickle cell disease and type 2 diabetes mellitus, and those 65 years of age and older.
Exclusion
- Under age 21, inability to communicate in English and other study languages, inability to complete anterior nasal swab sampling for COVID-19
Key Trial Info
Start Date :
November 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2021
Estimated Enrollment :
9120 Patients enrolled
Trial Details
Trial ID
NCT05315908
Start Date
November 1 2020
End Date
November 15 2021
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Diego
La Jolla, California, United States, 92093